Related Experiment Videos

Cardiac involvement in systemic lupus erythematosus

A Doria1, L Iaccarino, P Sarzi-Puttini

  • 1Division of Rheumatology, University of Padua, Padua, Italy. adoria@unipd.it

Lupus
|October 13, 2005
PubMed

Insights

Systemic lupus erythematosus (SLE) patients commonly experience pericarditis and other cardiac issues. Echocardiography is vital for early detection of these conditions, aiding in timely management and improved patient outcomes.

Area of Science:

  • Cardiology
  • Rheumatology
  • Internal Medicine

Background:

  • Pericarditis is the most frequent cardiac abnormality in patients with systemic lupus erythematosus (SLE).
  • Historically, cardiac manifestations in SLE were severe and life-threatening, often discovered post-mortem.
  • Contemporary understanding reveals that cardiac involvement in SLE is frequently mild and asymptomatic, detectable through noninvasive methods.

Purpose of the Study:

  • To highlight the prevalence and nature of cardiac abnormalities in SLE.
  • To emphasize the diagnostic utility of echocardiography in SLE patients.
  • To discuss the mechanisms and management of cardiovascular complications in SLE.

Main Methods:

  • Review of clinical observations and diagnostic techniques for cardiac manifestations in SLE.
  • Focus on the role of echocardiography in identifying pericarditis, valvular lesions, and myocardial dysfunction.
  • Analysis of causes for vascular occlusion, including premature atherosclerosis and antiphospholipid antibodies in SLE.

Main Results:

  • Echocardiography demonstrates high sensitivity and specificity for detecting cardiac abnormalities in SLE, including mild pericarditis.
  • Vascular complications, such as coronary artery disease (CAD), are common in SLE patients, primarily driven by premature atherosclerosis.
  • Cardiac manifestations in SLE are now often mild and asymptomatic, contrasting with historical severe presentations.

Conclusions:

  • Periodic echocardiography is recommended for SLE patients to monitor for cardiac abnormalities.
  • Managing traditional and SLE-specific risk factors is crucial to prevent atherosclerotic plaque development and CAD.
  • Early detection and management of cardiac involvement are essential for improving outcomes in SLE patients.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...